longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

STK

STK
----

LongbridgeAI

Weekly Recap | Lam Research +1.9%, consensus target above spot

Weekly Review
Sep 5, 2026 at 07:21 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Lam Research (LRCX) rose 1.9% this week to close at $307.65, while the S&P 500 gained 0.09%, putting the stock about 1.81 percentage points ahead of the benchmark. It was a volatile week, with an amplitude of 10.64%. Early pressure gave way to a sharp late-week rebound: shares opened at $303.19 on Monday (Aug 31), slid through Tuesday and Wednesday to a weekly low of $278.04 on Wednesday, then recovered from Thursday into Friday. Friday’s rally pushed LRCX to a weekly high of $310.

The Week

Lam Research (LRCX) rose 1.9% this week to close at $307.65, while the S&P 500 gained 0.09%, putting the stock about 1.81 percentage points ahead of the benchmark. It was a volatile week, with an amplitude of 10.64%. Early pressure gave way to a sharp late-week rebound: shares opened at $303.19 on Monday (Aug 31), slid through Tuesday and Wednesday to a weekly low of $278.04 on Wednesday, then recovered from Thursday into Friday. Friday’s rally pushed LRCX to a weekly high of $310.30 before it settled at $307.65, leaving a long upper wick and suggesting sellers remain active at higher levels.

Key Events

The most direct corporate development was a 27% dividend increase, announced early in the week and quickly picked up by the market. Insider disposals followed: Chief Legal Officer Ava Harter sold 5,000 shares, and Senior Vice President Varadarajan Seshasayee sold roughly $17.44 million worth of common stock. Institutional positioning was mixed, with NS Partners and Symphony Financial adding, while Nan Shan Life reduced its stake by 39,237 shares. Mid-week, a UBS downgrade and rising US Treasury yields pressured the stock, contributing to the Tuesday and Wednesday declines. From Thursday onward, a broader semiconductor rebound lifted LRCX, which at one point traded more than 5% higher on Friday before giving back part of the gain into the close.

Analyst Ratings

Of the 35 analysts covering Lam Research, 25 rate it buy, 4 rate it overweight, and 6 rate it hold, with no underweight or sell ratings. The consensus rating is strong buy, and the consensus target price of $370.87 sits about 20.5% above the latest price. Individual targets span a wide range from $290 to $500, pointing to meaningful dispersion in views. Within the semiconductor materials and equipment industry, LRCX ranks third out of 31 names.

The Week Ahead

There are no LRCX-specific earnings due next week, so macro data will be the main driver. On Thursday, Sep 10, the US releases initial jobless claims, final demand PPI and core PPI, along with 10-year Treasury auction results, which could keep the focus on yields and inflation. The NFIB small business optimism index lands on Tuesday, Sep 8, with existing home sales and wholesale sales also due on Thursday. If rate expectations continue to climb, high-multiple tech names will face another test.

In Short

Lam Research’s week mixed a strong late rebound with unresolved tensions. A dividend boost and a broader semiconductor rally powered Friday’s jump, while insider selling, a UBS downgrade and rising Treasury yields created counterpressure. Sell-side views lean positive: the consensus is strong buy and the target price is about 20.5% above spot, though a P/E of roughly 53x leaves the valuation stretched. The next few sessions hinge on how inflation and labour data reshape rate expectations, and whether the chip-sector bounce can hold.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Login to unlock2,523characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Lam Research

Lam Research

USLRCX

+0.07%

LRCX 2X Long ETF

LRCX 2X Long ETF

USLRCU